• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人溃疡性结肠炎患者就诊时疾病严重程度的种族/族裔特异性差异:一项横断面研究。

Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.

作者信息

Castaneda Garland, Liu Benny, Torres Sharon, Bhuket Taft, Wong Robert J

机构信息

Department of Medicine, Alameda Health System - Highland Hospital, Oakland, CA, USA.

Division of Gastroenterology and Hepatology, Alameda Health System - Highland Hospital, 1411 East 31st Street, Highland Hospital - Highland, Care Pavilion 5th Floor, Endoscopy Unit, Oakland, CA, 94602, USA.

出版信息

Dig Dis Sci. 2017 Oct;62(10):2876-2881. doi: 10.1007/s10620-017-4733-5. Epub 2017 Aug 30.

DOI:10.1007/s10620-017-4733-5
PMID:28856475
Abstract

BACKGROUND

While ulcerative colitis (UC) is well studied in Caucasian populations, less data are available on UC patients of racial/ethnic minorities, including variations in disease severity at presentation.

AIM

To evaluate race/ethnicity-specific disparities in UC disease presentation among an ethnically diverse underserved population.

METHODS

We performed a cross-sectional study of all consecutive UC adults among a large ethnically diverse safety-net hospital from July 2014 to May 2016 to compare race/ethnicity-specific disparities in severity of disease at presentation. Severity was evaluated using the clinician-based simple clinical colitis activity index (SCCAI) and the Mayo score at time of presentation. Multivariate ordered logistic regression models were used to evaluate associations with SCCAI and Mayo scores.

RESULTS

Among 98 UC patients (56.1% male, mean age 40.1 (SD 14.2), 32.0% were African-American, 26.7% Hispanic, 16.0% Asian, and 20.0% Caucasian. Mean Mayo score was 6.6 and mean SCCAI score was 6.5. When stratified by race/ethnicity, SCCAI scores were significantly higher in non-Caucasians compared to Caucasians (7.0 vs 4.6, p = 0.03) and in Asians compared to Caucasians (8.0 vs 4.6, p = 0.02). There was a trend toward higher mean SCCAI in Hispanics compared to Caucasians (6.9 vs 4.6, p = 0.07). Mayo scores at presentation demonstrated similar trends. On multivariate logistic regression, Asians (OR 5.26, 95% CI 1.24-22.42) and Hispanics (OR 3.74; 95% CI 1.02-13.66) had more severe disease at presentation than Caucasians based on SCCAI.

CONCLUSIONS

Among a diverse underserved cohort of UC patients, racial/ethnic minority patients with UC, specifically Asians and Hispanics, had more severe disease at presentation compared to Caucasians. The differences may reflect disparities in timely access to specialty care and treatment and deserves greater attention and research.

摘要

背景

虽然溃疡性结肠炎(UC)在白种人群体中已有充分研究,但关于种族/族裔少数群体UC患者的数据较少,包括疾病初发时严重程度的差异。

目的

评估在一个种族多样化的医疗服务不足人群中,UC疾病初发时种族/族裔特异性差异。

方法

我们对2014年7月至2016年5月期间一家大型种族多样化安全网医院中所有连续性UC成年患者进行了横断面研究,以比较疾病初发时种族/族裔特异性严重程度差异。使用基于临床医生的简单临床结肠炎活动指数(SCCAI)和初发时的梅奥评分来评估严重程度。采用多变量有序逻辑回归模型评估与SCCAI和梅奥评分的关联。

结果

98例UC患者中(56.1%为男性,平均年龄40.1岁(标准差14.2),32.0%为非裔美国人,26.7%为西班牙裔,16.0%为亚裔,20.0%为白种人。平均梅奥评分为6.6,平均SCCAI评分为6.5。按种族/族裔分层时,非白种人SCCAI评分显著高于白种人(7.0对4.6,p = 0.03),亚裔高于白种人(8.0对4.6,p = 0.02)。西班牙裔平均SCCAI有高于白种人的趋势(6.9对4.6,p = 0.07)。初发时的梅奥评分显示类似趋势。多变量逻辑回归分析显示,基于SCCAI,亚裔(比值比5.26,95%置信区间1.24 - 22.42)和西班牙裔(比值比3.74;95%置信区间1.02 - 13.66)初发时疾病比白种人更严重。

结论

在一个多样化的医疗服务不足的UC患者队列中,UC种族/族裔少数群体患者,特别是亚裔和西班牙裔,初发时疾病比白种人更严重。这些差异可能反映了在及时获得专科护理和治疗方面的差距,值得更多关注和研究。

相似文献

1
Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.成人溃疡性结肠炎患者就诊时疾病严重程度的种族/族裔特异性差异:一项横断面研究。
Dig Dis Sci. 2017 Oct;62(10):2876-2881. doi: 10.1007/s10620-017-4733-5. Epub 2017 Aug 30.
2
Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization.在一个综合性医疗机构中,溃疡性结肠炎患者的医疗利用和结局存在种族和民族差异。
Dig Dis Sci. 2014 Feb;59(2):287-94. doi: 10.1007/s10620-013-2908-2. Epub 2013 Oct 31.
3
Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009.外周动脉疾病血管内治疗结局的种族差异:对加利福尼亚州医院的评估,2005 - 2009年
Ann Vasc Surg. 2015 Jul;29(5):950-9. doi: 10.1016/j.avsg.2015.01.006. Epub 2015 Mar 7.
4
Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes.高血压伴或不伴糖尿病患者的种族和民族白蛋白尿检测。
Am J Nephrol. 2019;50(1):48-54. doi: 10.1159/000500706. Epub 2019 Jun 5.
5
Birth hospital and racial and ethnic differences in severe maternal morbidity in the state of California.加利福尼亚州产妇严重发病率的分娩医院和种族与民族差异。
Am J Obstet Gynecol. 2021 Feb;224(2):219.e1-219.e15. doi: 10.1016/j.ajog.2020.08.017. Epub 2020 Aug 13.
6
Comparison of the natural history of ulcerative colitis in African Americans and non-Hispanic Caucasians: a historical cohort study.非裔美国人和非西班牙裔白种人溃疡性结肠炎自然史的比较:一项历史队列研究。
Inflamm Bowel Dis. 2012 Apr;18(4):743-9. doi: 10.1002/ibd.21796. Epub 2011 Jun 17.
7
Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States.美国亚裔美国人住院急性心肌梗死死亡率的种族/族裔差异。
BMC Health Serv Res. 2018 May 16;18(1):370. doi: 10.1186/s12913-018-3180-0.
8
Racial disparities in the outcomes of superficial vein treatments for chronic venous insufficiency.慢性静脉功能不全的浅静脉治疗结局存在种族差异。
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):789-798.e3. doi: 10.1016/j.jvsv.2019.12.076. Epub 2020 Mar 21.
9
The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.患者简单临床结肠炎活动指数 (P-SCCAI) 可检测缓解期溃疡性结肠炎 (UC) 疾病活动:P-SCCAI 与基于临床医生的 SCCAI 和生物标志物的比较。
J Crohns Colitis. 2013 Dec;7(11):890-900. doi: 10.1016/j.crohns.2012.11.007. Epub 2012 Dec 24.
10
Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia.加拿大不列颠哥伦比亚省温哥华住院成年炎症性肠病患者年发病率的种族差异。
Can J Gastroenterol. 2011 Feb;25(2):73-7. doi: 10.1155/2011/640920.

引用本文的文献

1
Trends and disparities in inflammatory bowel disease and cardiovascular disease-related mortality in the United States from 1999 to 2023: A CDC WONDER analysis.1999年至2023年美国炎症性肠病和心血管疾病相关死亡率的趋势与差异:疾病控制与预防中心的WONDER分析
Int J Cardiol Cardiovasc Risk Prev. 2025 May 22;26:200438. doi: 10.1016/j.ijcrp.2025.200438. eCollection 2025 Sep.
2
The Association of Race, Ethnicity, and Insurance Status With Outcomes in Hospitalized Patients With Ulcerative Colitis.种族、族裔和保险状况与溃疡性结肠炎住院患者预后的关联
Gastro Hep Adv. 2022 Jul 31;1(6):985-992. doi: 10.1016/j.gastha.2022.07.016. eCollection 2022.
3

本文引用的文献

1
Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences.美国炎症性肠病中的种族和少数民族:疾病特征及差异的系统评价
Inflamm Bowel Dis. 2016 Aug;22(8):2023-40. doi: 10.1097/MIB.0000000000000835.
2
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.奥扎莫德诱导和维持治疗溃疡性结肠炎。
N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248.
3
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
Metagenomic analysis reveals distinct changes in the gut microbiome of obese Chinese children.
宏基因组分析揭示了肥胖中国儿童肠道微生物组的明显变化。
BMC Genomics. 2023 Nov 29;24(1):721. doi: 10.1186/s12864-023-09805-4.
4
Racial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online Survey.炎症性肠病患者的种族和民族差异:一项在线调查。
Inflamm Bowel Dis. 2024 Sep 3;30(9):1467-1474. doi: 10.1093/ibd/izad194.
5
Managing Pregnancy and Nursing Affecting African American Women with Inflammatory Bowel Disease: Clinical Outcomes and Parenthood.管理影响患有炎症性肠病的非裔美国女性的妊娠和哺乳:临床结果与为人父母情况
Med Res Arch. 2023 Jun;11(6). doi: 10.18103/mra.v11i6.3784. Epub 2023 Jun 26.
6
Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.炎症性肠病相关结直肠癌:游离血红蛋白α链(红细胞外渗被巨噬细胞吞噬的产物)引起的转化和转化风险。
Medicina (Kaunas). 2023 Jul;59(7). doi: 10.3390/medicina59071254. Epub 2023 Jul 6.
7
Inflammatory bowel disease type influences development of elevated liver enzymes.炎症性肠病的类型会影响肝酶升高的发展。
JGH Open. 2022 Nov 3;6(12):846-853. doi: 10.1002/jgh3.12831. eCollection 2022 Dec.
8
Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.存在健康差异的不同社区中的神经血管功能障碍——对痴呆症和阿尔茨海默病的影响
Front Neurosci. 2022 Jun 29;16:915405. doi: 10.3389/fnins.2022.915405. eCollection 2022.
9
Combination of vedolizumab and immunomodulators in ulcerative colitis.维多珠单抗与免疫调节剂联合用于溃疡性结肠炎
J Gastroenterol Hepatol. 2021 Dec;36(12):3556. doi: 10.1111/jgh.15686. Epub 2021 Sep 22.
10
Asians Have Higher Risk of Developing Pancreatic Necrosis in Inflammatory Bowel Disease Patient Population: A National Inpatient Sample Database Study.亚洲炎症性肠病患者发生胰腺坏死的风险更高:一项全国住院患者样本数据库研究。
Cureus. 2020 Sep 21;12(9):e10573. doi: 10.7759/cureus.10573.
克罗恩病和溃疡性结肠炎表型的遗传决定因素:一项基因关联研究。
Lancet. 2016 Jan 9;387(10014):156-67. doi: 10.1016/S0140-6736(15)00465-1. Epub 2015 Oct 18.
4
Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.非住院溃疡性结肠炎的医学管理临床实践指南:多伦多共识。
Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4.
5
The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.克罗恩病和溃疡性结肠炎的遗传学——现状与展望
Scand J Gastroenterol. 2015 Jan;50(1):13-23. doi: 10.3109/00365521.2014.990507.
6
Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.在一家大型三级保健医院,炎症性肠病的临床表现和疾病进程因种族而异。
Dig Dis Sci. 2014 Sep;59(9):2228-35. doi: 10.1007/s10620-014-3160-0. Epub 2014 Apr 22.
7
The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States.美国门诊炎症性肠病患者中种族和社会经济地位对免疫调节剂和抗肿瘤坏死因子使用的影响。
Am J Gastroenterol. 2013 Dec;108(12):1824-30. doi: 10.1038/ajg.2013.192.
8
Vedolizumab as induction and maintenance therapy for ulcerative colitis.维得利珠单抗用于溃疡性结肠炎的诱导缓解和维持治疗。
N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734.
9
Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population.美国军事医疗保健人群中按年龄、性别、种族和地理位置划分的炎症性肠病患病率。
Inflamm Bowel Dis. 2013 Jun;19(7):1421-7. doi: 10.1097/MIB.0b013e318281334d.
10
Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population.美国商业保险人群中克罗恩病和溃疡性结肠炎患病率的近期趋势。
Dig Dis Sci. 2013 Feb;58(2):519-25. doi: 10.1007/s10620-012-2371-5. Epub 2012 Aug 29.